Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Pwint

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Netherlands Journal of Medicine|March 24, 2010
A dysfunctional central venous lineF Azam, T Pwint, A Gupta
Expert Review of Anticancer Therapy|June 10, 2006
Treatment options for older woman with early breast cancerM Myat Moe, T Pwint Pwint, R C F Leonard
British Journal of Cancer|January 7, 2012
Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumoursE Dean, M R Middleton, T Pwint, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Netherlands Journal of Medicine|March 24, 2010
A dysfunctional central venous lineF Azam, T Pwint, A Gupta
Expert Review of Anticancer Therapy|June 10, 2006
Treatment options for older woman with early breast cancerM Myat Moe, T Pwint Pwint, R C F Leonard
British Journal of Cancer|January 7, 2012
Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumoursE Dean, M R Middleton, T Pwint, et al.
Pageof 1